Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold

Pharmaceutical Research

Volumn 28, Issue 6, 2011, Pages 1282-1293

  Nelson, Devin M ^a,b   Baraniak, Priya R ^a,b,c   Ma, Zuwei ^b   Guan, Jianjun ^b,d   Mason, N Scott ^e   Wagner, William R ^a,b,f  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Ohio State University   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

elastomer; growth factor delivery; polyurethane; scaffold; tissue engineering

Indexed keywords

MOLECULAR SCAFFOLD; POLY(ESTER URETHANE)UREA; POLYMER; SCATTER FACTOR; SOMATOMEDIN C; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CELL ASSAY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MECHANICS; PRIORITY JOURNAL;

ABSORBABLE IMPLANTS; ANIMALS; BALB 3T3 CELLS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ELASTOMERS; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; POLYESTERS; TISSUE ENGINEERING;

EID: 79959909344     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0391-z     Document Type: Article

References (54)

1. F Rehfeldt AJ Engler A Eckhardt F Ahmed DE Discher 2007 Cell responses to the mechanochemical microenvironment-implications for regenerative medicine and drug delivery Adv Drug Deliv Rev 59 1329 39 17900747 10.1016/j.addr.2007.08.007 1:CAS:528:DC%2BD2sXhtlals7bN (Pubitemid 350088256)
2. RG Wells 2008 The role of matrix stiffness in regulating cell behavior Hepatology 47 1394 400 18307210 10.1002/hep.22193 1:CAS:528:DC%2BD1cXkslOjsLY%3D (Pubitemid 351547925)
3. Ramaswami P, Wagner WR. Cardiovascular tissue engineering. In: Guelcher S, Hollinger JO, editors. An Introduction to biomaterials. Boca Raton: CRC; 2006. p. 461-84.
4. J Guan MS Sacks EJ Beckman WR Wagner 2002 Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine J Biomed Mater Res 61 493 503 12115475 10.1002/jbm.10204 1:CAS:528:DC%2BD38XltVGmtr4%3D (Pubitemid 34666063)
5. GA Skarja KA Woodhouse 2001 In vitro degradation and erosion of degradable, segmented polyurethanes containing an amino acid-based chain extender J Biomater Sci Polym Ed 12 851 73 11718481 10.1163/156856201753113060 1:CAS:528:DC%2BD3MXotlChs7s%3D (Pubitemid 33040004)
6. J Guan WR Wagner 2005 Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity Biomacromolecules 6 2833 42 16153125 10.1021/bm0503322 1:CAS:528: DC%2BD2MXmsFCqtb4%3D (Pubitemid 41388299)
7. S Gogolewski G Galletti 1986 Degradable, microporous vascular prosthesis from segmented polyurethane Colloid Polym Sci 264 854 8 10.1007/BF01410635 1:CAS:528:DyaL2sXitlahsg%3D%3D (Pubitemid 17496188)
8. KL Fujimoto K Tobita WD Merryman J Guan N Momoi DB Stolz, et al. 2007 An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction J Am Coll Cardiol 49 2292 300 17560295 10.1016/j.jacc.2007.02.050 1:CAS:528:DC%2BD2sXmtlWis7w%3D (Pubitemid 46856822)
9. W He A Nieponice L Soletti Y Hong B Gharaibeh M Crisan, et al. 2010 Pericyte-based human tissue engineered vascular grafts Biomaterials 31 8235 44 20684982 10.1016/j.biomaterials.2010.07.034 1:CAS:528:DC%2BC3cXhtFWntLjE
10. A Hafeman B Li T Yoshii K Zienkiewicz J Davidson S Guelcher 2008 Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration Pharm Res 25 2387 99 18516665 10.1007/s11095-008-9618-z 1:CAS:528:DC%2BD1cXhtFOru7zO
11. AE Hafeman KJ Zienkiewicz E Carney B Litzner C Stratton JC Wenke, et al. 2010 Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds J Biomater Sci Polym Ed 21 95 112 20040156 10.1163/156856209X410256 1:CAS:528:DC%2BC3cXisFymsbo%3D
12. WN Sivak J Zhang S Petoud EJ Beckman 2010 Incorporation of ionic ligands accelerates drug release from LDI-glycerol polyurethanes Acta Biomater 6 144 53 19524075 10.1016/j.actbio.2009.06.013 1:CAS:528:DC%2BC3cXotVSkuw%3D%3D
13. JJ Stankus DO Freytes SF Badylak WR Wagner 2008 Hybrid nanofibrous scaffolds from electrospinning of a synthetic biodegradable elastomer and urinary bladder matrix J Biomater Sci Polym Ed 19 635 52 18419942 10.1163/156856208784089599 1:CAS:528:DC%2BD1cXntFaltbc%3D (Pubitemid 351535786)
14. J Zhang BA Doll EJ Beckman JO Hollinger 2003 A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering J Biomed Mater Res A 67A 389 400 10.1002/jbm.a.10015 1:CAS:528:DC%2BD3sXhtVShur7N (Pubitemid 37522444)
15. J Guan JJ Stankus WR Wagner 2007 Biodegradable elastomeric scaffolds with basic fibroblast growth factor release J Control Release 120 70 8 17509717 10.1016/j.jconrel.2007.04.002 1:CAS:528:DC%2BD2sXmt1Glsbg%3D (Pubitemid 46874620)
16. B Li KV Brown JC Wenke SA Guelcher 2010 Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model J Control Release 145 221 30 20382191 10.1016/j.jconrel.2010.04.002 1:CAS:528:DC%2BC3cXosF2nur0%3D
17. LL Lao SS Venkatraman NA Peppas 2009 A novel model and experimental analysis of hydrophilic and hydrophobic agent release from biodegradable polymers J Biomed Mater Res A 90 1054 65 18671269
18. B Amsden 2003 A model for osmotic pressure driven release from cylindrical rubbery polymer matrices J Control Release 93 249 58 14644575 10.1016/j.jconrel.2003.08.007 1:CAS:528:DC%2BD3sXptlCmsrg%3D (Pubitemid 37485947)
19. BG Amsden 2008 Biodegradable elastomers in drug delivery Expert Opin Drug Deliv 5 175 87 18248317 10.1517/17425247.5.2.175 1:CAS:528:DC%2BD1cXhsVSju70%3D (Pubitemid 351308310)
20. GLY Woo ML Yang HQ Yin F Jaffer MW Mittelman JP Santerre 2002 Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones J Biomed Mater Res 59 35 45 11745535 10.1002/jbm.1214 1:CAS:528:DC%2BD3MXptVaqu70%3D (Pubitemid 33131597)
21. N Rosenthal A Musaro 2002 Gene therapy for cardiac cachexia? Int J Cardiol 85 185 91 12163223 10.1016/S0167-5273(02)00253-X
22. PC Schulze J Fang KA Kassik J Gannon M Cupesi C MacGillivray, et al. 2005 Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction Circ Res 97 418 26 16051886 10.1161/01.RES.0000179580.72375.c2 1:CAS:528:DC%2BD2MXpsVWrt7k%3D (Pubitemid 41298171)
23. S Hayashi H Aso K Watanabe H Nara MT Rose S Ohwada, et al. 2004 Sequence of IGF-I, IGF-II, and HGF expression in regenerating skeletal muscle Histochem Cell Biol 122 427 34 15480739 10.1007/s00418-004-0704-y 1:CAS:528: DC%2BD2cXhtVSitLvN (Pubitemid 40379012)
24. S Machida FW Booth 2004 Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation Proc Nutr Soc 63 337 40 15294052 10.1079/PNS2004354 1:CAS:528:DC%2BD2cXms12msbg%3D (Pubitemid 38787487)
25. ME Padin-Iruegas Y Misao ME Davis VF Segers G Esposito T Tokunou, et al. 2009 Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction Circulation 120 876 87 19704095 10.1161/CIRCULATIONAHA.109.852285 1:CAS:528:DC%2BD1MXhtVGhu7bN
26. H Jin JM Wyss R Yang R Schwall 2004 The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure Curr Pharm Des 10 2525 33 15320761 10.2174/1381612043383863 1:CAS:528:DC%2BD2cXlslWjtr4%3D (Pubitemid 38997432)
27. HF Duan CT Wu DL Wu Y Lu HJ Liu XQ Ha, et al. 2003 Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor Mol Ther 8 467 74 12946320 10.1016/S1525-0016(03)00186-2 1:CAS:528:DC%2BD3sXms1yisrs%3D (Pubitemid 37161468)
28. H Ueda T Nakamura K Matsumoto Y Sawa H Matsuda 2001 A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats Cardiovasc Res 51 41 50 11399246 10.1016/S0008-6363(01)00272-3 1:CAS:528:DC%2BD3MXktVOisrY%3D (Pubitemid 32523053)
29. S Pulavendran M Rajam C Rose AB Mandal 2010 Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro IET Nanobiotechnol 4 51 20726671 10.1049/iet-nbt.2009.0014 1:CAS:528:DC%2BC3cXhsVejt7nF
30. N Kato K Nakanishi K Nemoto 2009 Efficacy of HGF gene transfer for various nervous injuries and disorders Cent Nerv Syst Agents Med Chem 9 300 6 20021363 1:CAS:528:DC%2BD1MXhsFWisLbF
31. J Guan KL Fujimoto MS Sacks WR Wagner 2005 Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications Biomaterials 26 3961 71 15626443 10.1016/j.biomaterials. 2004.10.018 1:CAS:528:DC%2BD2MXisFWn (Pubitemid 40038787)
32. JA Kricker CL Towne SM Firth AC Herington Z Upton 2003 Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin Endocrinology 144 2807 15 12810534 10.1210/en.2002-221086 1:CAS:528:DC%2BD3sXkvF2ksLg%3D (Pubitemid 36819880)
33. XJ Liu Q Xie YF Zhu C Chen N Ling 2001 Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex J Biol Chem 276 32419 22 11445558 10.1074/jbc.C100299200 1:CAS:528:DC%2BD3MXmvFCmsr4%3D
34. M Singh B Shirley K Bajwa E Samara M Hora D O'Hagan 2001 Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles J Control Release 70 21 8 11166404 10.1016/S0168-3659(00)00313-8 1:CAS:528:DC%2BD3MXovV2rug%3D%3D (Pubitemid 32144789)
35. F Bussolino MF Di Renzo M Ziche E Bocchietto M Olivero L Naldini, et al. 1992 Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 119 629 41 1383237 10.1083/jcb.119.3.629 1:CAS:528:DyaK38XmtlWru78%3D
36. F Gu R Neufeld B Amsden 2007 Sustained release of bioactive therapeutic proteins from a biodegradable elastomeric device J Control Release 117 80 9 17126945 10.1016/j.jconrel.2006.09.077 1:CAS:528:DC%2BD2sXht1Cmsrs%3D (Pubitemid 46161863)
37. F Gu R Neufeld B Amsden 2006 Osmotic-driven release kinetics of bioactive therapeutic proteins from a biodegradable elastomer are linear, constant, similar, and adjustable Pharm Res 23 782 9 16550470 10.1007/s11095-006-9750-6 1:CAS:528:DC%2BD28XktFWjsb4%3D
38. K Hirose A Marui Y Arai T Nomura S Inoue K Kaneda, et al. 2006 Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection J Vasc Surg 44 377 82 16890872 10.1016/j.jvs.2006.03.043 (Pubitemid 44142921)
39. B Li JM Davidson SA Guelcher 2009 The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds Biomaterials 30 3486 94 19328544 10.1016/j.biomaterials.2009.03.008 1:CAS:528:DC%2BD1MXlvFGqtLg%3D
40. F Cui D Cun A Tao M Yang K Shi M Zhao, et al. 2005 Preparation and characterization of melittin-loaded poly (dl-lactic acid) or poly (dl-lactic-co-glycolic acid) microspheres made by the double emulsion method J Control Release 107 310 9 16255081 10.1016/j.jconrel.2005.07.001 1:CAS:528:DC%2BD2MXhtVShtr%2FO (Pubitemid 41316293)
41. CC Lin AT Metters 2006 Hydrogels in controlled release formulations: network design and mathematical modeling Adv Drug Deliv Rev 58 1379 408 17081649 10.1016/j.addr.2006.09.004 1:CAS:528:DC%2BD28Xht1CnsLzJ
42. S Cometa I Bartolozzi A Corti F Chiellini E De Giglio E Chiellini 2010 Hydrolytic and microbial degradation of multi-block polyurethanes based on poly([var epsilon]-caprolactone)/poly(ethylene glycol) segments Polym Degrad Stab 95 2013 21 10.1016/j.polymdegradstab.2010.07.007 1:CAS:528: DC%2BC3cXhtFWqu7nL
43. JP Santerre K Woodhouse G Laroche RS Labow 2005 Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials Biomaterials 26 7457 70 16024077 10.1016/j.biomaterials.2005.05.079 1:CAS:528:DC%2BD2MXot1WktL8%3D (Pubitemid 41133597)
44. RS Labow E Meek JP Santerre 2001 Hydrolytic degradation of poly(carbonate)-urethanes by monocyte-derived macrophages Biomaterials 22 3025 33 11575477 10.1016/S0142-9612(01)00049-7 1:CAS:528:DC%2BD3MXmt1yju7w%3D (Pubitemid 32768710)
45. RS Labow E Meek JP Santerre 2001 Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation J Biomed Mater Res 54 189 97 11093178 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8 1:CAS:528:DC%2BD3cXoslahsbk%3D
46. H Peng J Ling J Liu N Zhu X Ni Z Shen 2010 Controlled enzymatic degradation of poly(caprolactone)-based copolymers in the presence of porcine pancreatic lipase Polym Degrad Stab 95 643 50 10.1016/j.polymdegradstab.2009.12. 005 1:CAS:528:DC%2BC3cXivFeisr0%3D
47. RS Labow DJ Erfle JP Santerre 1995 Neutrophil-mediated degradation of segmented polyurethanes Biomaterials 16 51 9 7718693 10.1016/0142-9612(95)91096- H 1:CAS:528:DyaK2MXjvVGiu7k%3D
48. RS Labow D Sa LA Matheson DLM Dinnes J Paul Santerre 2005 The human macrophage response during differentiation and biodegradation on polycarbonate-based polyurethanes: dependence on hard segment chemistry Biomaterials 26 7357 66 16005062 10.1016/j.biomaterials.2005.05.048 1:CAS:528:DC%2BD2MXot1Wkt78%3D (Pubitemid 41133587)
49. YW Tang RS Labow I Revenko JP Santerre 2002 Influence of surface morphology and chemistry on the enzyme catalyzed biodegradation of polycarbonate-urethanes J Biomater Sci Polym Ed 13 463 83 12160304 10.1163/156856202320253965 (Pubitemid 34814823)
50. C Pérez IJ Castellanos HR Costantino W Al-Azzam K Griebenow 2002 Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers J Pharm Pharmacol 54 301 13 11902796 10.1211/0022357021778448 (Pubitemid 34232331)
51. ME Davis PC Hsieh T Takahashi Q Song S Zhang RD Kamm, et al. 2006 Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc Natl Acad Sci USA 103 8155 60 16698918 10.1073/pnas.0602877103 1:CAS:528: DC%2BD28Xlt1ChtL8%3D (Pubitemid 43801068)
52. C Carrascosa I Torres-Aleman C Lopez-Lopez E Carro L Espejo S Torrado, et al. 2004 Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration Biomaterials 25 707 14 14607509 10.1016/S0142-9612(03) 00562-3 1:CAS:528:DC%2BD3sXosFOrt78%3D (Pubitemid 37357284)
53. XM Lam ET Duenas AL Daugherty N Levin JL Cleland 2000 Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes J Control Release 67 281 92 10825561 10.1016/S0168-3659(00)00224-8 1:CAS:528:DC%2BD3cXjsVegtrg%3D (Pubitemid 30303842)
54. K Tambara GU Premaratne G Sakaguchi N Kanemitsu X Lin H Nakajima, et al. 2005 Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft Circulation 112 I129 34 16159804